Table 2.
Estimate mean changes and SE in clinical outcomes by self-monitoring (SM) trajectory group from baseline to 3 and 6 months.
|
|
Baseline to 3 months | Baseline to 6 months | |||||
|
|
Lower SM group | Higher SM group | Between-group P value |
Lower SM group | Higher SM group | Between-group P value |
|
| Weight (kg), mean (SE) | −2.86 (1.23) | −5.98 (0.87)a | .02 | −3.48 (1.4) | −6.06 (0.87)a | .20 | |
| HbA1c (%), mean (SE) | −0.04 (0.16) | −0.46 (0.11)b | .02 | −0.03 (0.18) | −0.38 (0.11)c | .03 | |
| SBPd (mm Hg), mean (SE) | −0.01 (3.05) | −9.71 (2.26)e | .048 | −0.42 (3.42) | −6.44 (2.26) | .23 | |
| DBPf (mm Hg), mean (SE) | 2.15 (2.03) | −5.39 (1.49)b | .04 | 1.69 (2.29) | −2.59 (1.49) | .08 | |
aWithin-group: P<.001.
bWithin-group: P<.01.
cWithin-group: P<.05.
dSBP: systolic blood pressure.
eWithin-group: P<.001.
fDBP: diastolic blood pressure.